HESKA CORP·4

Jun 14, 6:27 PM ET

Eyl Steven M. 4

4 · HESKA CORP · Filed Jun 14, 2023

Insider Transaction Report

Form 4
Period: 2022-02-28
Eyl Steven M.
EVP, Commercial Operations
Transactions
  • Award

    Common Stock

    2023-06-13+33,11160,411 total
  • Award

    Common Stock

    2023-06-13+4,05664,467 total
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2023-06-131,9180 total
    Exercise: $39.76Exp: 2025-12-28Common Stock (1,918 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2023-06-131,3720 total
    Exercise: $72.85Exp: 2026-12-28Common Stock (1,372 underlying)
  • Disposition to Issuer

    Common Stock

    2023-06-13$120.00/sh64,467$7,736,0400 total
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2023-06-1328,3600 total
    Exercise: $60.94Exp: 2030-04-15Common Stock (28,360 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2023-06-131,4330 total
    Exercise: $69.77Exp: 2028-03-06Common Stock (1,433 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2023-06-1318,5670 total
    Exercise: $69.77Exp: 2028-03-06Common Stock (18,567 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2022-02-28+20,00020,000 total
    Exercise: $60.94From: 2022-02-28Exp: 2030-04-15Common Stock (20,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2023-06-1320,0000 total
    Exercise: $60.94From: 2022-02-28Exp: 2030-04-15Common Stock (20,000 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2023-06-131,6400 total
    Exercise: $60.94Exp: 2030-04-15Common Stock (1,640 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2023-06-133,0410 total
    Exercise: $39.76Exp: 2025-12-28Common Stock (3,041 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2023-06-131,1460 total
    Exercise: $18.13Exp: 2024-12-30Common Stock (1,146 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2023-06-137,6910 total
    Exercise: $72.85Exp: 2026-12-28Common Stock (7,691 underlying)
Footnotes (11)
  • [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, these shares of performance-based restricted stock of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
  • [F10]These stock options of the Issuer vested in monthly equal installments over four years through December 29, 2019.
  • [F11]These stock options of the Issuer vested in monthly equal installments over four years through December 29, 2020.
  • [F2]Includes 396 shares of common stock of the Issuer purchased under the Issuer's employee stock purchase plan on May 26, 2023.
  • [F3]Pursuant to the Merger Agreement, these performance-based restricted stock units were fully accelerated assuming target level of performance immediately prior to the effectiveness of the merger.
  • [F4]Disposed of pursuant to the Merger Agreement in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.
  • [F5]Stock options of the Issuer became vested and exercisable upon achieving performance vesting conditions on February 28, 2022.
  • [F6]Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.
  • [F7]These stock options of the Issuer vested in two equal installments on December 31, 2021 and on December 31, 2022.
  • [F8]These stock options of the Issuer vested in three approximately equal annual installments beginning on March 7, 2019 and ending on March 7, 2021.
  • [F9]These stock options of the Issuer vested in monthly equal installments over four years through December 31, 2018.

Documents

1 file
  • 4
    form4.xmlPrimary